MICHAEL D. CASEY

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Capstone Holding Corp.

Filing Date Source Excerpt
2004-04-29 Michael D. Casey, 58, became a director of the Company in January 2004, filling a newly created vacancy on the Board of Directors. ... The Nominating Committee consists of Mr. Holliman and Dr. White, both of whom are independent directors under NASD Marketplace Rule 4200(a)(15). ... Mr. Casey was selected by the Company’s Nominating Committee and the Board of Directors as a result of a candidate search conducted by the Nominating Committee. ... The Board nominated Mr. Trotter, Mr. Casey and Dr. Feldman for election as Class I directors for this year’s annual meeting of stockholders. ... The Company issued options to acquire 20,000 non-qualified shares to each non-employee director on December 31, 2003.
2005-03-07 Michael D. Casey, 59, became a director of the Company in January 2004. During the year ended 2004, the Company paid non-employee directors an annual retainer of $24,000 payable quarterly in advance.
2006-04-14 Michael D. Casey, 60, became a director of the Company in January 2004... During the year ended December 31, 2005, the Company paid non-employee directors an annual retainer of $24,000 payable quarterly in advance.
2007-04-09 Michael D. Casey, 61, became a director of the Company in January 2004. ... (3) Member of the Compensation Committee. ... Compensation of Directors ... Michael D. Casey Director 28,000 20,000 46,000 94,000

DURECT CORP

Filing Date Source Excerpt
2006-04-27 Mr. Casey was Chairman, President and Chief Executive Officer of Matrix Pharmaceuticals, Inc. and held various executive roles in pharmaceutical companies.
2007-04-30 Mr. Casey was Chairman, President and Chief Executive Officer of Matrix Pharmaceuticals, Inc. and held various positions at Johnson & Johnson companies.
2008-04-29 Mr. Casey was Chairman, President and Chief Executive Officer of Matrix Pharmaceuticals, Inc. and held various executive roles in pharmaceutical companies.
2009-04-29 Mr. Casey was Chairman, President and Chief Executive Officer of Matrix Pharmaceuticals, Inc.
2010-04-29 Mr. Casey's executive leadership experience with pharmaceutical companies and his expertise with respect to sales, marketing and commercialization of pharmaceutical products are among the qualifications he brings to the Board and his service as a Director of the Company.
2011-04-28 Mr. Casey’s executive leadership experience with pharmaceutical companies and his expertise with respect to sales, marketing and commercialization of pharmaceutical products are among the qualifications he brings to the Board and his service as a Director of the Company.
2012-04-26 Mr. Casey was Chairman, President and CEO of Matrix Pharmaceuticals and held various executive roles in pharmaceutical companies.
2013-04-29 Mr. Casey was Chairman, President and CEO of Matrix Pharmaceuticals and has executive leadership experience with pharmaceutical companies.

Sarepta Therapeutics, Inc.

Filing Date Source Excerpt
2010-05-04 Michael D. Casey(4) 103,750 Fees Earned or Paid in Cash, 5,500 Stock Awards, 18,592 Option Awards, Total 127,842

Data sourced from SEC filings. Last updated: 2026-02-03